Active 0 6 0 6 O
diarrhea 7 15 7 15 B-chronic_disease

Clinically 0 10 16 26 O
significant 11 22 27 38 O
cardiac 23 30 39 46 B-chronic_disease
disease 31 38 47 54 I-chronic_disease

ECOG 0 4 55 59 B-clinical_variable
( 5 6 60 61 I-clinical_variable
Eastern 6 13 61 68 I-clinical_variable
cooperative 14 25 69 80 I-clinical_variable
oncology 26 34 81 89 I-clinical_variable
group 35 40 90 95 I-clinical_variable
) 40 41 95 96 I-clinical_variable
performance 42 53 97 108 I-clinical_variable
status 54 60 109 115 I-clinical_variable
â‰¤2 61 63 116 118 O

Insufficient 0 12 119 131 B-chronic_disease
hepatic 13 20 132 139 I-chronic_disease
and 21 24 140 143 I-chronic_disease
renal 25 30 144 149 I-chronic_disease
function 31 39 150 158 I-chronic_disease

Must 0 4 159 163 O
have 5 9 164 168 O
progressed 10 20 169 179 O
following 21 30 180 189 O
standard 31 39 190 198 B-treatment
therapy 40 47 199 206 I-treatment
, 47 48 206 207 O
or 49 51 208 210 O
for 52 55 211 214 O
whom 56 60 215 219 O
, 60 61 219 220 O
in 62 64 221 223 O
the 65 68 224 227 O
opinion 69 76 228 235 O
of 77 79 236 238 O
the 80 83 239 242 O
Investigator 84 96 243 255 O

Tumors 0 6 256 262 B-cancer
harboring 7 16 263 272 O
known 17 22 273 278 O
activating 23 33 279 289 O
KRAS 34 38 290 294 O
, 38 39 294 295 O
NRAS 40 44 296 300 O
, 44 45 300 301 O
HRAS 46 50 302 306 O
, 50 51 306 307 O
BRAF 52 56 308 312 O
or 57 59 313 315 O
PTPN11 60 66 316 322 O
( 67 68 323 324 O
SHP2 68 72 324 328 O
) 72 73 328 329 O
mutations 74 83 330 339 O

female 0 6 340 346 B-gender

male 0 4 347 351 B-gender

willing 0 7 352 359 O
to 8 10 360 362 O
agree 11 16 363 368 O
to 17 19 369 371 O
not 20 23 372 375 O
father 24 30 376 382 O
a 31 32 383 384 O
child 33 38 385 390 O
/ 38 39 390 391 O
become 39 45 391 397 B-pregnancy
pregnant 46 54 398 406 I-pregnancy

